Literature DB >> 18187696

Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up.

Jing Xie1, Carol Brayne, Fiona E Matthews.   

Abstract

OBJECTIVES: To provide estimates of survival after onset of dementia by age, sex, self reported health, disability, and severity of cognitive impairment.
DESIGN: Analysis of participants from prospective population based cohort study in 1991-2003, with follow-up of dementia status in all individuals after two and six years (in one centre) and 10 years and in subsamples additionally at six and eight years and mortality until 2005.
SETTING: Multicentre population based study in England and Wales: two rural and three urban centres. PARTICIPANTS: 438 participants who developed dementia from a population based study of 13 004 individuals aged 65 years and over drawn from primary care population registers. MAIN OUTCOME MEASURES: Sociodemographic factors, cognitive function, specific health conditions, and self reported health collected at each interview. Cox's proportional hazards regression models were used to identify predictors of mortality from the selected variables in people who received diagnosis of dementia according the study's criteria.
RESULTS: By December 2005, 356 of the 438 (81%) participants who developed dementia during the study had died. Estimated median survival time from onset of dementia to death was 4.1 years (interquartile range 2.5-7.6) for men and 4.6 years (2.9-7.0) for women. There was a difference of nearly seven years in survival between the younger old and the oldest people with dementia: 10.7 (25th centile 5.6) for ages 65-69; 5.4 (interquartile range 3.4-8.3) for ages 70-79; 4.3 (2.8-7.0) for ages 80-89, and 3.8 (2.3-5.2) years for ages > or =90. Significant factors that predicted mortality in the presence of dementia during the follow-up included sex, age of onset, and disability.
CONCLUSION: These analyses give a population based estimated median survival for incident dementia of 4.5 years. Such estimates can be used for prognosis and planning for patients, carers, service providers, and policy makers.

Entities:  

Mesh:

Year:  2008        PMID: 18187696      PMCID: PMC2223023          DOI: 10.1136/bmj.39433.616678.25

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  31 in total

1.  APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.

Authors:  K Juva; A Verkkoniemi; P Viramo; T Polvikoski; K Kainulainen; K Kontula; R Sulkava
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

2.  Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over.

Authors:  R Neale; C Brayne; A L Johnson
Journal:  Int J Epidemiol       Date:  2001-12       Impact factor: 7.196

3.  Survival to late dementia in Dutch nursing home patients.

Authors:  Raymond T C M Koopmans; John L P Ekkerink; Chris van Weel
Journal:  J Am Geriatr Soc       Date:  2003-02       Impact factor: 5.562

4.  Cognitive reserve and mortality in dementia: the role of cognition, functional ability and depression.

Authors:  M I Geerlings; D J Deeg; B W Penninx; B Schmand; C Jonker; L M Bouter; W van Tilburg
Journal:  Psychol Med       Date:  1999-09       Impact factor: 7.723

5.  Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature.

Authors:  M E Dewey; P Saz
Journal:  Int J Geriatr Psychiatry       Date:  2001-08       Impact factor: 3.485

6.  Mortality with dementia: results from a French prospective community-based cohort.

Authors:  C Helmer; P Joly; L Letenneur; D Commenges; J F Dartigues
Journal:  Am J Epidemiol       Date:  2001-10-01       Impact factor: 4.897

7.  Survival study of vascular dementia in Rochester, Minnesota.

Authors:  David S Knopman; Walter A Rocca; Ruth H Cha; Steven D Edland; Emre Kokmen
Journal:  Arch Neurol       Date:  2003-01

8.  Predictors of survival in African American patients with AD, VaD, or stroke without dementia.

Authors:  Sally Freels; David L Nyenhuis; Philip B Gorelick
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

9.  An investigation of whether factors associated with short-term attrition change or persist over ten years: data from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Authors:  Fiona E Matthews; Mark Chatfield; Carol Brayne
Journal:  BMC Public Health       Date:  2006-07-18       Impact factor: 3.295

10.  Dementia before death in ageing societies--the promise of prevention and the reality.

Authors:  Carol Brayne; Lu Gao; Michael Dewey; Fiona E Matthews
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

View more
  94 in total

1.  Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging.

Authors:  Vincenzo Solfrizzi; Emanuele Scafato; Vincenza Frisardi; Daniele Sancarlo; Davide Seripa; Giancarlo Logroscino; Marzia Baldereschi; Gaetano Crepaldi; Antonio Di Carlo; Lucia Galluzzo; Claudia Gandin; Domenico Inzitari; Stefania Maggi; Alberto Pilotto; Francesco Panza
Journal:  Age (Dordr)       Date:  2011-04-26

Review 2.  Different models of frailty in predementia and dementia syndromes.

Authors:  F Panza; V Solfrizzi; V Frisardi; S Maggi; D Sancarlo; F Adante; G D'Onofrio; D Seripa; A Pilotto
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 3.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

4.  Validation of risk prediction tools in elderly patients who initiate dialysis.

Authors:  Dohui Hwang; Eunbin Lee; Samel Park; Byung Chul Yoo; Suyeon Park; Kyoung Jin Choi; Songhee Oh; Mi Jung Kim; Hyoungnae Kim; Jin Seok Jeon; Hyunjin Noh; Dong Cheol Han; Soon Hyo Kwon
Journal:  Int Urol Nephrol       Date:  2019-05-27       Impact factor: 2.370

Review 5.  Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Authors:  Houshang Amiri; Kolsoum Saeidi; Parvin Borhani; Arash Manafirad; Mahdi Ghavami; Valerio Zerbi
Journal:  ACS Chem Neurosci       Date:  2013-09-26       Impact factor: 4.418

6.  Caring for people with dementia.

Authors:  Murna Downs; Barbara Bowers
Journal:  BMJ       Date:  2008-01-10

7.  Does cognition predict mortality in midlife? Results from the Whitehall II cohort study.

Authors:  Séverine Sabia; Alice Guéguen; Michael G Marmot; Martin J Shipley; Joël Ankri; Archana Singh-Manoux
Journal:  Neurobiol Aging       Date:  2008-06-09       Impact factor: 4.673

8.  Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.

Authors:  Jose Martin Rabey; Evgenia Dobronevsky
Journal:  J Neural Transm (Vienna)       Date:  2016-09-08       Impact factor: 3.575

9.  Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.

Authors:  Ipek Baysal; Gulberk Ucar; Merve Gultekinoglu; Kezban Ulubayram; Samiye Yabanoglu-Ciftci
Journal:  J Neural Transm (Vienna)       Date:  2016-02-24       Impact factor: 3.575

10.  Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.

Authors:  Massimo Musicco; Katie Palmer; Giovanna Salamone; Federica Lupo; Roberta Perri; Serena Mosti; Gianfranco Spalletta; Fulvia di Iulio; Carla Pettenati; Luca Cravello; Carlo Caltagirone
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.